Microbial Growth in the Suture Thread, After Application of Different Antiseptic Gels in Mandibular Third Molars Extraction

NCT ID: NCT03188289

Last Updated: 2017-06-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

21 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-01-20

Study Completion Date

2014-09-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized clinical trial in which investigators will compare the antimicrobial effect and inducer of cicatrization as well as the degree of postoperative pain in patients who are extracted the lower third molars.

After the surgery, different bioadhesive gels will be applied in the area of the surgical wound and we will evaluate the aforementioned parameters.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Introduction: Surgical removal of the third molars is one of the most frequent procedures in oral surgery. Healing of the wound is initially sought by approximating the edges using a suturing technique. Adherence and microbiological accumulation of the suture during the period that it remains in the mouth, which can serve as a focus for odontogenic infections. The use of oral antiseptics before and after the surgery is an efficient method for microbial reduction. The purposes of this project were to evaluate the microbial growth in the suture thread on different culture means after the post-surgical application of the gels under study, while assessing the intensity of post-surgical pain and the degree of healing of the surgical wound.

Material and methods: It is a randomized and blind clinical trial. 21 patients participated (42 wisdom teeth), who consulted the unit for a surgical tooth extraction for at least the two lower wisdom teeth. The evaluated bioadhesive gels were: Chlorhexidine gel at 0.2 % (Bexident Gel Gingival®), Chlorhexidine gel at 0.2% + Chitosan (Bexident Post®) and hyaluronic acid gel (ODDENT®). A neutral water-based gel without any active ingredients was also used HISPAGEL 200® (Acofarma, Madrid, Spain) as the control agent. An assessment of the post-surgical healing, the microbiological analysis of the suture thread and the post-surgical pain was developed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wisdom Teeth Oral Surgery Third Molar Surgery Bioadhesive Gel Suture Bacteria Antiseptic Gel Chistosan Clorhexidine Gel Bacteria Clorhexidine-chitosan Bacterial Growth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo gel

The placebo gel is used by all patients on one side of the mouth and serves as a control group.

Group Type PLACEBO_COMPARATOR

Placebo gel

Intervention Type DRUG

Placebo is the control group treated with a placebo gel.

Clorhexidine gel

Intervention Type DRUG

Clorhexidine will be compare with placebo, clorhexidine-chitosán and hyaluronic acid bioadhesive gels

Clorhexidine-Chitosan gel

Intervention Type DRUG

Clorhexidine-chitosan will be compare with placebo, clorhexidine and hyaluronic acid bioadhesive gels.

Hyaluronic Acid gel

Intervention Type DRUG

Hyaluronic acid will be compare with placebo, clorhexidine, clorhexidine-chitosan bioadhesive gels

Clorhexidine gel

Chlorhexidine gel is one of three gels used to compare the placebo gel and will be used on the contralateral side to the side assigned as placebo in a third of the participants.

Group Type ACTIVE_COMPARATOR

Placebo gel

Intervention Type DRUG

Placebo is the control group treated with a placebo gel.

Clorhexidine gel

Intervention Type DRUG

Clorhexidine will be compare with placebo, clorhexidine-chitosán and hyaluronic acid bioadhesive gels

Clorhexidine-Chitosan gel

Intervention Type DRUG

Clorhexidine-chitosan will be compare with placebo, clorhexidine and hyaluronic acid bioadhesive gels.

Hyaluronic Acid gel

Intervention Type DRUG

Hyaluronic acid will be compare with placebo, clorhexidine, clorhexidine-chitosan bioadhesive gels

Clorhexidine-Chitosan gel

Clorhexidine-chitosan gel is one of three gels used to compare the placebo gel and will be used on the contralateral side to the side assigned as placebo in a third of the participants.

Group Type ACTIVE_COMPARATOR

Placebo gel

Intervention Type DRUG

Placebo is the control group treated with a placebo gel.

Clorhexidine gel

Intervention Type DRUG

Clorhexidine will be compare with placebo, clorhexidine-chitosán and hyaluronic acid bioadhesive gels

Clorhexidine-Chitosan gel

Intervention Type DRUG

Clorhexidine-chitosan will be compare with placebo, clorhexidine and hyaluronic acid bioadhesive gels.

Hyaluronic Acid gel

Intervention Type DRUG

Hyaluronic acid will be compare with placebo, clorhexidine, clorhexidine-chitosan bioadhesive gels

Hyaluronic acid gel

Hialuronic acid gel is one of three gels used to compare the placebo gel and will be used on the contralateral side to the side assigned as placebo in a third of the participants.

Group Type ACTIVE_COMPARATOR

Placebo gel

Intervention Type DRUG

Placebo is the control group treated with a placebo gel.

Clorhexidine gel

Intervention Type DRUG

Clorhexidine will be compare with placebo, clorhexidine-chitosán and hyaluronic acid bioadhesive gels

Clorhexidine-Chitosan gel

Intervention Type DRUG

Clorhexidine-chitosan will be compare with placebo, clorhexidine and hyaluronic acid bioadhesive gels.

Hyaluronic Acid gel

Intervention Type DRUG

Hyaluronic acid will be compare with placebo, clorhexidine, clorhexidine-chitosan bioadhesive gels

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo gel

Placebo is the control group treated with a placebo gel.

Intervention Type DRUG

Clorhexidine gel

Clorhexidine will be compare with placebo, clorhexidine-chitosán and hyaluronic acid bioadhesive gels

Intervention Type DRUG

Clorhexidine-Chitosan gel

Clorhexidine-chitosan will be compare with placebo, clorhexidine and hyaluronic acid bioadhesive gels.

Intervention Type DRUG

Hyaluronic Acid gel

Hyaluronic acid will be compare with placebo, clorhexidine, clorhexidine-chitosan bioadhesive gels

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Hyspagel 200 Bexident encías Bexident Post Oddent

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: between 18 and 39 years.
* Good general health.
* Availability during the study.
* No current odontological treatments or foreseen during the study period.
* Acceptance and compliance with the prescribed oral hygiene instructions.
* Agreement to not used mouthwashes or toothpastes with antiseptic agents during the study period.

Exclusion Criteria

* Use of antimicrobial mouthwashes or toothpastes during the period during which the suture remains in the mouth.
* Diabetes.
* Smoking.
* Degenerative diseases.
* Deficient oral health (cavities, periodontal disease, pathologies of the oral mucosa...).
* Wearing prosthetic or orthodontic devices.
* Amoxicillin allergy.
* Pregnant or lactating women.
Minimum Eligible Age

18 Years

Maximum Eligible Age

39 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Santiago de Compostela

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Samuel Rodríguez Zorrilla

DDS, MSc.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Samuel Rodríguez Zorrilla, DDS,MSc

Role: PRINCIPAL_INVESTIGATOR

University of Santiago de Compostela

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Complications After Lower Third Molar Surgery
NCT03130933 COMPLETED PHASE1/PHASE2